Le Lézard
Classified in: Business
Subjects: TNM, ATY

SHAREHOLDER ALERT: WeissLaw LLP Investigates Proteon Therapeutics, Inc.


NEW YORK, Nov. 21, 2019 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Proteon Therapeutics, Inc. ("PRTO" or the "Company") (NASDAQ: PRTO) in connection with the proposed acquisition of the Company by ArTara Therapeutics, Inc.  

WeissLaw LLP (PRNewsfoto/WeissLaw LLP)

If you own PRTO shares and wish to discuss this investigation or have any questions concerning this notice or your rights or interests, visit our website:

http://www.weisslawllp.com/proteon-therapeutics-inc/

Or please contact:
Joshua Rubin, Esq.
WeissLaw LLP
1500 Broadway, 16th Floor
New York, NY  10036
(212) 682-3025
(888) 593-4771
[email protected]

WeissLaw is investigating whether PRTO's Board acted to maximize shareholder value prior to entering into the acquisition agreement.  Notably, at close of the transaction, PRTO shareholders will own a meager 10% of the combined company. 

Additionally, the Company recently announced significant improvements in its financial results for the third quarter of 2019.  It reported a net loss of $1.5 million, representing an improvement of $3.00 million year-over-year when compared to the $4.5 million it reported in the same period of the previous year.  

Given these facts, WeissLaw is concerned whether the proposed acquisition undervalues the Company, and whether all material information related to the proposed acquisition is fully and fairly disclosed. 

WeissLaw LLP has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties.  We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases.  If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at [email protected]

 

SOURCE WeissLaw LLP


These press releases may also interest you

at 06:40
iClick Interactive Asia Group Limited ("iClick" or the "Company") , a leading enterprise and marketing cloud platform in China that empowers worldwide brands with full-stack consumer lifecycle solutions, today announced the appointment of Ms....

at 06:35
Apogee Enterprises, Inc. will report its fiscal 2024 fourth quarter and full-year results on Thursday, April 18, 2024, before the market opens. The company will also host a conference call to discuss its financial results. This conference call will...

at 06:35
Metals Acquisition Limited ARBN 671 963 198 , a private limited company incorporated under the laws of Jersey, Channel Islands ("MAC" or the "Company") announces its Annual Report for the financial year ended 31 December 2023 ("2023 Annual Report")....

at 06:31
Hangzhou Tigermed Consulting Co., Ltd. ("Tigermed" or the "company") (Stock code: 300347.SZ / 3347.HK), a leading global provider of integrated research and development solutions for biopharmaceutical and medical device industry, announced its annual...

at 06:30
Verde AgriTech Ltd ("Verde" or the "Company") announces its financial results for the full year ended December 31, 2023 ("FY 2023") and the fourth quarter 2023 ("Q4 2023"), as audited by Ernst & Young ("EY"). The FY 2023 audited results were...

at 06:30
Hut 8 Corp. ("Hut 8" or the "Company"), a leading, vertically integrated operator of large-scale energy infrastructure and one of North America's largest Bitcoin miners, today announced its financial results for the six months ended...



News published on and distributed by: